1-3 of 3
Isobelle Galeon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Safety and Efficacy Results from a Phase 1/2 Study of Zinc Finger Nuclease-Modified Autologous Hematopoietic Stem Cells for Sickle Cell Disease (PRECIZN-1)

Asif Alavi, Mehrdad Abedi, Suhag Parikh, Richard Boismenu, Michael Chen, Ben L. Hsu, Bettina M. Cockroft, Isobelle Galeon, Pablo Rendo, Mark C. Walters
Journal: Blood
Blood (2022) 140 (Supplement 1): 4907–4909.
https://doi.org/10.1182/blood-2022-163725
Published: 2022
Journal Articles

Quantitative Systems Pharmacology Model of Sickle Cell Disease and Response to Gene Editing Therapy to Support Clinical Development of SAR445136 (BIVV003)

Chanchala Kaddi, Danielle Holz, Mengdi Tao, Isobelle Galeon, David Reiner, Pablo Rendo, Susana Zaph
Journal: Blood
Blood (2021) 138 (Supplement 1): 1860.
https://doi.org/10.1182/blood-2021-147330
Published: 2021
Journal Articles

Preliminary Safety and Efficacy Results from Precizn-1: An Ongoing Phase 1/2 Study on Zinc Finger Nuclease-Modified Autologous CD34+ HSPCs for Sickle Cell Disease (SCD)

Asif Alavi, Lakshmanan Krishnamurti, Mehrdad Abedi, Isobelle Galeon, David Reiner, Sharon E Smith, Lin Wang, Anne Ramezi, Pablo Rendo, Mark C. Walters
Journal: Blood
Blood (2021) 138 (Supplement 1): 2930.
https://doi.org/10.1182/blood-2021-151650
Published: 2021